Assets, Current of Whitehawk Therapeutics, Inc. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Whitehawk Therapeutics, Inc. quarterly Assets, Current in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
Whitehawk Therapeutics, Inc. Assets, Current for the quarter ending 30 Sep 2025 was $165,036,000, a 113% increase year-over-year.
Source SEC data: View on sec.gov

Assets, Current, Quarterly (USD)

Assets, Current, YoY Quarterly Change (%)

Whitehawk Therapeutics, Inc. Quarterly Assets, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$165,036,000	+$87,721,000	+113%	30 Sep 2025	10-Q	06 Nov 2025	2025	Q3
Q2 2025	$178,671,000	+$85,666,000	+92%	30 Jun 2025	10-Q	07 Aug 2025	2025	Q2
Q1 2025	$232,614,000	+$130,041,000	+127%	31 Mar 2025	10-Q	08 May 2025	2025	Q1
Q4 2024	$61,287,000	-$63,299,000	-51%	31 Dec 2024	10-Q	06 Nov 2025	2025	Q3
Q3 2024	$77,315,000	-$55,569,000	-42%	30 Sep 2024	10-Q	06 Nov 2024	2024	Q3
Q2 2024	$93,005,000	-$51,918,000	-36%	30 Jun 2024	10-Q	07 Aug 2024	2024	Q2
Q1 2024	$102,573,000	-$62,357,000	-38%	31 Mar 2024	10-Q	08 May 2024	2024	Q1
Q4 2023	$124,586,000	-$55,443,000	-31%	31 Dec 2023	10-K	28 Mar 2025	2024	FY
Q3 2023	$132,884,000	-$56,979,000	-30%	30 Sep 2023	10-Q	08 Nov 2023	2023	Q3
Q2 2023	$144,923,000	+$20,588,000	+17%	30 Jun 2023	10-Q	09 Aug 2023	2023	Q2
Q1 2023	$164,930,000	+$29,310,000	+22%	31 Mar 2023	10-Q	10 May 2023	2023	Q1
Q4 2022	$180,029,000	+$28,757,000	+19%	31 Dec 2022	10-K	13 Mar 2024	2023	FY
Q3 2022	$189,863,000	+$27,845,000	+17%	30 Sep 2022	10-Q	09 Nov 2022	2022	Q3
Q2 2022	$124,335,000	+$86,940,411	+232%	30 Jun 2022	10-Q	10 Aug 2022	2022	Q2
Q1 2022	$135,620,000	+$94,620,747	+231%	31 Mar 2022	10-Q	12 May 2022	2022	Q1
Q4 2021	$151,272,000	+$132,587,000	+710%	31 Dec 2021	10-K	29 Mar 2023	2022	FY
Q3 2021	$162,018,000	+$112,434,708	+227%	30 Sep 2021	10-Q	10 Nov 2021	2021	Q3
Q2 2021	$37,394,589	-$8,040,176	-18%	30 Jun 2021	10-Q	11 Aug 2021	2021	Q2
Q1 2021	$40,999,253	+$5,607,036	+16%	31 Mar 2021	10-Q	17 May 2021	2021	Q1
Q4 2020	$18,685,000	-$20,885,475	-53%	31 Dec 2020	10-K	17 Mar 2022	2021	FY
Q3 2020	$49,583,292	+$4,778,897	+11%	30 Sep 2020	10-Q	10 Nov 2020	2020	Q3
Q2 2020	$45,434,765	-$3,354,598	-6.9%	30 Jun 2020	10-Q	12 Aug 2020	2020	Q2
Q1 2020	$35,392,217	-$18,906,800	-35%	31 Mar 2020	10-Q	07 May 2020	2020	Q1
Q4 2019	$39,570,475	-$24,413,608	-38%	31 Dec 2019	10-K	11 Mar 2021	2020	FY
Q3 2019	$44,804,395	-$25,235,155	-36%	30 Sep 2019	10-Q	07 Nov 2019	2019	Q3
Q2 2019	$48,789,363	-$20,636,153	-30%	30 Jun 2019	10-Q	08 Aug 2019	2019	Q2
Q1 2019	$54,299,017	+$39,688,930	+272%	31 Mar 2019	10-Q	09 May 2019	2019	Q1
Q4 2018	$63,984,083	+$43,084,613	+206%	31 Dec 2018	10-K	16 Mar 2020	2019	FY
Q3 2018	$70,039,550	+$44,175,773	+171%	30 Sep 2018	10-Q	07 Nov 2018	2018	Q3
Q2 2018	$69,425,516	+$39,781,100	+134%	30 Jun 2018	10-Q	14 Aug 2018	2018	Q2
Q1 2018	$14,610,087	-$21,511,121	-60%	31 Mar 2018	10-Q	15 May 2018	2018	Q1
Q4 2017	$20,899,470	+$18,673,147	+839%	31 Dec 2017	10-K	07 Mar 2019	2018	FY
Q3 2017	$25,863,777			30 Sep 2017	10-Q	13 Nov 2017	2017	Q3
Q2 2017	$29,644,416			30 Jun 2017	10-Q	10 Aug 2017	2017	Q2
Q1 2017	$36,121,208			31 Mar 2017	10-Q	15 May 2017	2017	Q1
Q4 2016	$2,226,323			31 Dec 2016	10-K	15 Mar 2018	2017	FY
Q1 2013	$3,831^*	-$20,392		31 Mar 2013	10-Q	15 May 2013	2013	Q1
Q4 2012	$8,107^*	+$1,482		31 Dec 2012	10-Q	15 May 2013	2013	Q1
Q3 2012	$11,266^*	+$761		30 Sep 2012	10-Q	14 Nov 2012	2012	Q3
Q2 2012	$15,561^*	+$81		30 Jun 2012	10-Q	14 Aug 2012	2012	Q2
Q1 2012	$24,223^*			31 Mar 2012	10-Q	15 May 2012	2012	Q1
Q4 2011	$6,625^*	-$22,773		31 Dec 2011	10-K	28 Mar 2013	2012	FY
Q3 2011	$10,505^*			30 Sep 2011	10-Q	14 Nov 2011	2011	Q3
Q2 2011	$15,480^*			30 Jun 2011	10-Q	15 Aug 2011	2011	Q2
Q4 2010	$29,398^*			31 Dec 2010	10-K	30 Mar 2012	2011	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.